Stay updated with breaking news from Nasdaq Adma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com upgraded shares of ADMA Biologics (NASDAQ:ADMA – Free Report) from a sell rating to a hold rating in a report published on Saturday morning. Several other analysts have also recently commented on the company. Cantor Fitzgerald raised their target price on ADMA Biologics from $5.00 to $6.00 and gave the company an overweight rating […]
StockNews.com upgraded shares of ADMA Biologics (NASDAQ:ADMA – Free Report) from a sell rating to a hold rating in a research report released on Friday morning. ADMA has been the subject of a number of other reports. HC Wainwright boosted their target price on shares of ADMA Biologics from $4.50 to $5.00 and gave the […]
ADMA Biologics, Inc. (NASDAQ:ADMA – Get Free Report) Director Young Kwon acquired 25,000 shares of ADMA Biologics stock in a transaction on Thursday, August 24th. The shares were bought at an average cost of $3.90 per share, for a total transaction of $97,500.00. Following the completion of the transaction, the director now owns 277,401 shares […]
ADMA Biologics, Inc. (NASDAQ:ADMA – Get Free Report) CFO Brian Lenz sold 211,578 shares of ADMA Biologics stock in a transaction on Tuesday, August 15th. The shares were sold at an average price of $4.60, for a total value of $973,258.80. Following the completion of the sale, the chief financial officer now owns 782,013 shares […]
ADMA Biologics (NASDAQ:ADMA – Free Report) had its target price boosted by HC Wainwright from $4.50 to $5.00 in a research note issued to investors on Thursday morning, Benzinga reports. HC Wainwright currently has a buy rating on the biotechnology company’s stock. Several other brokerages also recently weighed in on ADMA. StockNews.com downgraded shares of […]